Tower Research Capital LLC (Trc) Graybug Vision, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.76 - $1.25 $145 - $238	-191 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.13 - $1.93 $2,508 - $4,284	-2,220 Reduced 92.08%	191 $0
Q4 2021 Feb 14, 2022	BUY	$1.74 - $3.6 $2,763 - $5,716	1,588 Added 192.95%	2,411 $4,000
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.17 $39,059 - $63,503	-12,283 Reduced 93.72%	823 $3,000
Q2 2021 Aug 16, 2021	BUY	$3.53 - $6.1 $360 - $622	102 Added 0.78%	13,106 $71,000
Q1 2021 May 17, 2021	BUY	$5.55 - $35.0 $68,142 - $429,730	12,278 Added 1691.18%	13,004 $72,000
Q4 2020 Feb 16, 2021	BUY	$13.05 - $33.93 $9,474 - $24,633	726 New	726 $21,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.